37 results about "Absorbable Implants" patented technology

Two (or more), -component, body-implantable, absorbable, biocompatible, putty, and non-putty hemostatic tamponades for use in surgery. Component 1 is a finely powdered bulking material, preferably less than 50 microns, e.g. the calcium, magnesium, aluminum, or barium salts of saturated or unsaturated carboxylic acids containing about 6 to 22 carbon atoms, hydroxyapatite, DBM, polyglycolide, polylactide, poldioxinones, polycaprolactones, absorbable glasses, gelatin, collagens, mono, and polysaccharides starches. Component 2, a dispersing vehicle, may be esters of C8-C18 monohydric alcohols with C2-C6 aliphatic monocarboxylic acids; C2-C18 monohydric alcohols with polycarboxylic acids; C8-C30 monohydric alcohols; tocopherol and esters thereof with C2-C10 aliphatic monocarboxylic acids or polycarboxylic acids; absorbable 10-14C hydrocarbons; free carboxylic acids such as oleic, capric, and lauric; dialkyl ethers and ketones; alkyl aryl ethers and ketones, polyhydroxy compounds and esters and ethers thereof; (ethylene oxide / propylene oxide copolymers), oils e.g. olive oil, castor oil and triglycerides.

Two (or more), -component, body-implantable, absorbable, biocompatible, putty, and non-putty hemostatic tamponades for use in surgery. Component 1 is a finely powdered bulking material, preferably less than 50 microns, e.g. the calcium, magnesium, aluminum, or barium salts of saturated or unsaturated carboxylic acids containing about 6 to 22 carbon atoms, hydroxyapatite, DBM, polyglycolide, polylactide, poldioxinones, polycaprolactones, absorbable glasses, gelatin, collagens, mono, and polysaccharides starches. Component 2, a dispersing vehicle, may be esters unsubstituted and N-substituted pyrrolidones of C8-C18 monohydric alcohols with C2-C6 aliphatic monocarboxylic acids; C2-C18 monohydric alcohols with polycarboxylic acids; C8-C30 monohydric alcohols; tocopherol and esters thereof with C2-C10 aliphatic monocarboxylic acids or polycarboxylic acids; absorbable 10-14C hydrocarbons; free carboxylic acids such as oleic, capric, and lauric; dialkyl ethers and ketones; alkyl aryl ethers and ketones, polyhydroxy compounds and esters and ethers thereof; (ethylene oxide / propylene oxide copolymers), oils e.g. olive oil, castor oil and triglycerides.

Absorbable implants for breast surgery that conform to the breast parenchyma and surrounding chest wall have been developed. These implants support newly lifted breast parenchyma, and / or a breast implant. The implants have mechanical properties sufficient to support a reconstructed breast, and allow the in-growth of tissue into the implant as it degrades. The implants have a strength retention profile allowing the support of the breast to be transitioned from the implant to regenerated host tissue, without significant loss of support. Three-dimensional implants for use in minimally invasive mastopexy / breast reconstruction procedures are also described, that confer shape to a patient's breast. These implants are self-reinforced, can be temporarily deformed, implanted in a suitably dissected tissue plane, and resume their preformed three-dimensional shape. The implants are preferably made from poly-4-hydroxybutyrate (P4HB) and copolymers thereof. The implants have suture pullout strengths that can resist the mechanical loads exerted on the reconstructed breast.

Absorbable implants for breast surgery that conform to the breast parenchyma and surrounding chest wall have been developed. These implants support newly lifted breast parenchyma, and / or a breast implant. The implants have mechanical properties sufficient to support a reconstructed breast, and allow the in-growth of tissue into the implant as it degrades. The implants have a strength retention profile allowing the support of the breast to be transitioned from the implant to regenerated host tissue, without significant loss of support. Three-dimensional implants for use in minimally invasive mastopexy / breast reconstruction procedures are also described, that confer shape to a patient's breast. These implants are self-reinforced, can be temporarily deformed, implanted in a suitably dissected tissue plane, and resume their preformed three-dimensional shape. The implants are preferably made from poly-4-hydroxybutyrate (P4HB) and copolymers thereof. The implants have suture pullout strengths that can resist the mechanical loads exerted on the reconstructed breast.

Full contour absorbable implants for breast surgery redistribute breast volume between the breast's upper and lower poles in exact and desirable ratios. The implants preferably redistribute breast volume so that the upper pole breast volume is 20-40% of the total volume, and the lower pole breast volume is 60-80% of the total volume. The implants are also designed to provide specific curvatures to the poles of the breast, and to angulate the nipple areolar complex slightly skyward so that the patient's nipple is positioned at an angle above the nipple meridian reference line. The implants are designed to be transitory, with sufficient strength retention to allow transition from support of the breast by the implant to support by regenerated host tissue growing in and around the implants, without any significant loss of support during or subsequent to remodeling. The implants may optionally be used with permanent breast implants.

Expandable absorbable implants have been developed that are suitable for breast reconstruction following mastectomy. The implants can be implanted in the vicinity of a tissue expander, for example, by suturing to the detached edge of the pectoralis major muscle to function as a pectoralis extender, and used to form a sling for a tissue expander. The implants, which permit tissue-ingrowth and slowly degrade, can be expanded in the breast using a tissue expander in order to form a pocket for a permanent breast implant. After expansion, the tissue expander can be removed and replaced with a permanent breast implant. The expandable implants help reduce patient discomfort resulting from tissue expansion, and avoid the need to use allografts or xenografts to create the pocket for the tissue expander. The expandable absorbable implant preferably comprises poly-4-hydroxybutyrate or copolymer thereof.

An absorbable implant comprises a basic compound made of a material which can be absorbed by the body of the implant recipient. A coating which contains titanium partially covers the basic compound, so that the latter comprises coating-free zones for the body to engage and absorb.

The invention relates to a ligament fixation system comprising a suspensory steel plate and an absorbable implant and an application method of the system. The ligament fixation system includes the suspensory steel plate, the absorbable implant, a suspensory thread and a suture. The implant is in a cylindrical shape, parallel open pore passages are symmetrically distributed in the periphery of theimplant, an arc-shaped groove smoothly connected with a ligament graft is formed in the top of the implant, and a square groove for facilitating suture fixation is formed in the bottom of the implant.The implant makes the contact area of the ligament graft and the surface of a bone tunnel increased, prevents synovial fluid from permeating into the bone tunnel, effectively reduces the occurrence of a 'windshield wiper' effect, and prevents friction and breakage of the ligament graft. The application of the absorbable material is beneficial to achieving true tendon-bone healing. The ligament fixation system has wide raw material sources, and is convenient to manufacture, fast to assemble and easy to use, the tendon processing steps can be simplified, the operation time can be shortened, andthe firmness of the ligament graft can be significantly improved.

Full contour absorbable implants for breast surgery redistribute breast volume between the breast's upper and lower poles in exact and desirable ratios. The implants preferably redistribute breast volume so that the upper pole breast volume is 20-40% of the total volume, and the lower pole breast volume is 60-80% of the total volume. The implants are also designed to provide specific curvatures to the poles of the breast, and to angulate the nipple areolar complex slightly skyward so that the patient's nipple is positioned at an angle above the nipple meridian reference line. The implants are designed to be transitory, with sufficient strength retention to allow transition from support of the breast by the implant to support by regenerated host tissue growing in and around the implants, without any significant loss of support during or subsequent to remodeling. The implants may optionally be used with permanent breast implants.

An implantable tissue filler including a particulate material suspended in a carrier, the particulate material having more than about 70% by weight magnesium and about 2-20% by weight lithium, wherein the particulate material is substantially free of rare earth metals.

The present invention is directed to a biodegradable alloy suitable for use in a medical implant, comprising at least 50% iron by weight, at least 25% manganese by weight, and at least 0.01% sulfur and / or selenium by weight, wherein the biodegradable alloy is nonmagnetic. The present invention also provides a method of producing a biodegradable alloy with a desirable degradation rate.

The present disclosure is directed, in part, to a curable composition, a method for augmenting a structure in a patient with a resorbable biocompatible polymer, and a biodegradable, resorbable implant comprising a biocompatible copolymer. An exemplary embodiment of the curable composition comprises (a) 60 wt. % to 95 wt. % of one or more vinyl ester monomers and / or vinylcarbonate monomers, wherein said one or more vinyl ester monomers and / or vinylcarbonate monomers are respectively selected from compounds of the general formulas (I) and (II) below:wherein n, m R1 and R2 have the meaning defined herein; (b) 0.1 to 40 wt. % of one or more multifunctional thiols; and (c) 0 to 10 wt. % of a biocompatible polymerization initiator.

An iron based and absorbable implanted prefabricated tube (1) for medical device and preparation method therefor, and a medical device prepared by the prefabricated tube and preparation method therefor. The average nitrogen content of nitrogen in the prefabricated tube is from 0.04-0.4 wt. % or 0.02-0.04 wt. %. The prefabricated tube can be cut along the length direction directly by laser or by machining to obtain multiple absorbable implanted medical devices.

The present invention relates to an antibiotic preparation for absorbable and non-absorbable implants used in human and veterinary medicine for the treatment of local microbial infections in hard and soft tissues. This antibiotic preparation is a mixture, which is composed of at least an amphoteric component and an antibiotic component, an anhydrous organic auxiliary component, an inorganic auxiliary component and a biologically active auxiliary component. Representatives of the amphoteric components are alkyl sulfates, aryl sulfates, alkylaryl sulfates, cycloalkyl sulfates, alkylcycloalkyl sulfates, alkyl sulfamate, cycloalkyl Sulfamate, alkylcycloalkylsulfamate, arylsulfamate, alkyl arylsulfamate, alkylsulfonate, fatty acid-2-sulfonate, arylsulfonate , Alkyl aryl sulfonate, cycloalkyl sulfonate, alkyl cycloalkyl sulfonate, alkyl pyrosulfate, cycloalkyl pyrosulfate, alkyl disulfonate, cycloalkyl disulfonate acid salt, aryl disulfonate, alkylaryl disulfonate, aryl trisulfonate and alkylaryl trisulfonate, the antibiotic component is selected from the following antibiotics: aminoglycoside antibiotics, Lincosamide antibiotics, 4-quinolone antibiotics or tetracycline antibiotics. The antibiotic preparation of the present invention can sustainably release biologically active substances.

The invention belongs to the field of medical instrument sterilization, and relates to a sterilization method for an absorbable implant and matched instrument combined product. The method comprises the following steps: cleaning non-absorbable instrument sub-components in a clean room, assembling into a non-absorbable matched instrument, carrying out ethylene oxide sterilization or radiation sterilization on the non-absorbable matched instrument, assembling the absorbable implant consumables on the sterilized non-absorbable matched instrument in a clean room, and then performing ethylene oxide sterilization and desorption. By adopting the method provided by the invention, the contradictions that the absorbable implant consumables in the absorbable implant and the matched instrument combined product cannot be subjected to excessive sterilization due to the characteristic of easy degradation and the sterilization effect cannot be ensured due to the complex structure of the non-absorbable matched instrument can be effectively solved; and the method can guarantee that the absorbable implant consumables and matched instruments with complex structures can achieve the sterile effect at the same time, the performance of the absorbable implant consumables cannot be reduced, and important practical use value and significance are achieved.